Centene reported a full year (FY) 2025 net loss attributable to shareholders of USD (6.67) billion, compared to net earnings of USD 3.31 billion in FY 2024. Diluted loss per share was USD (13.53), down from diluted earnings per share of USD 6.31 in the prior year. Adjusted diluted EPS for FY 2025 was USD 2.08, compared to USD 7.17 in FY 2024. Total revenues for FY 2025 increased 19%, driven primarily by premium yield and membership growth. Centene continues to focus on serving underserved populations and now provides health products to more than 1 in 15 individuals nationwide, including Medicaid and Medicare members, as well as Health Insurance Marketplace participants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centene Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001071739-26-000049), on February 17, 2026, and is solely responsible for the information contained therein.